NCT05831111 2025-09-30A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsModernaTX, Inc.Phase 1 Active not recruiting482 enrolled
NCT00886496 2012-06-20Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and NeutropeniaEnzon Pharmaceuticals, Inc.Phase 1 Withdrawn